Browse Category

Mergers & Acquisitions News 31 October 2025 - 5 November 2025

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Google (GOOGL) Stock Today: Alphabet Rises on Apple–Siri AI Tie‑Up, Epic Play Store Settlement, and DOJ Nod for $32B Wiz Deal — Nov. 5, 2025

Updated Nov. 5, 2025 (19:51 UTC). This article rounds up the major, same‑day developments affecting Alphabet/Google stock. At a glance: Alphabet (NASDAQ: GOOGL) traded roughly 2% higher intraday as three catalysts landed on the same day: reports that Apple will use Google’s Gemini AI model to power a revamped Siri, a proposed settlement with Epic Games that reshapes Android app‑store…
Cheer Holding (CHR) Stock Skyrockets on Buyout Bids – Inside the AI Innovator’s Rollercoaster Ride

Cheer Holding (CHR) Stock Skyrockets on Buyout Bids – Inside the AI Innovator’s Rollercoaster Ride

Company Overview: A Niche Chinese Digital Ecosystem Cheer Holding, Inc. is a China-based provider of advanced mobile internet infrastructure and digital content platforms. Through its subsidiaries, Cheer offers advertising and content production services in the Chinese market. The company has built a suite of consumer apps and services under the “CHEERS” brand, aiming to create an integrated digital ecosystem. Its…
Dow Dips as Fed Fears Slam Tech Stocks – Hot Economic Data Rattles Wall Street (Sept 25, 2025)

Regional Banks Roar Back? Q3 Surprises, Mega‑Mergers—and the One Risk Still Haunting 2025

Key facts (updated Nov. 5, 2025): Q3 in one chartless glance: earnings stabilized, but credit is still a coin flip After two straight Fed cuts took the policy range down again in late October, the October Senior Loan Officer Opinion Survey painted a nuanced picture: tighter C&I standards on balance, but basically unchanged CRE standards and stronger demand for mortgages…
Metsera (MTSR) Stock Soars 20% Amid $10B Bidding War – Pfizer vs Novo Nordisk Face Off

Metsera (MTSR) Stock Soars 20% Amid $10B Bidding War – Pfizer vs Novo Nordisk Face Off

Metsera Stock Overview and Recent Performance Metsera’s stock has been on a meteoric rise in recent weeks, capped by a 20% jump on November 4, 2025 alone Reuters Reuters. The share price is now hovering in the low $70s Reuters, a remarkable increase from just around $30–$33 in mid-September before any takeover talks emerged Prnewswire. In fact, over the past…
Axcelis (ACLS) Stock Jumps on Q3 Earnings Beat and Veeco Merger: Key Insights & Outlook

Axcelis (ACLS) Stock Jumps on Q3 Earnings Beat and Veeco Merger: Key Insights & Outlook

Stock Price and Performance History Axcelis stock traded in the mid-$80s in early November 2025, rallying on earnings news. It closed around $86.24 on Nov 4, 2025, up about 5% for the day and roughly 8–9% over the two sessions surrounding its earnings report. This rebound comes after a soft October where ACLS had slid ~14% over a month Nasdaq,…
Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Background: Novo vs. Pfizer in the Weight-Loss Drug Race The fight for Metsera is driven by fierce competition in GLP-1 obesity drugs. Novo Nordisk is the maker of Wegovy/Ozempic, and Eli Lilly’s drugs recently overtook Wegovy in US market share Reuters. Novo’s new CEO Mike Doustdar and the company’s controlling foundation have pushed for bolder moves after days of sliding…
Kenvue (NYSE: KVUE) Stock Surges on $40B Buyout – Spin‑Off Saga, Tylenol Turmoil & Investor Outlook

Kenvue (NYSE: KVUE) Stock Surges on $40B Buyout – Spin‑Off Saga, Tylenol Turmoil & Investor Outlook

Company Overview & History Kenvue Inc. is a leading consumer health company formed from Johnson & Johnson’s storied consumer products division. The name “Kenvue” combines “ken” (knowledge) and “vue” (view), reflecting a vision of insight-driven care Wikipedia. As a spin-off, Kenvue took over J&J’s well-known retail brands, ranging from over-the-counter (OTC) medicines to skincare and baby care. Today its portfolio…
Evoke Pharma (EVOK) Stock Skyrockets on Buyout News – What’s Behind the Surge?

Evoke Pharma (EVOK) Stock Skyrockets on Buyout News – What’s Behind the Surge?

Stock Price and Recent Performance Year-to-date chart of Evoke Pharma (EVOK) stock through early November 2025. Shares were volatile throughout 2025, and the Q4 acquisition announcement (right end of chart) triggered a dramatic spike to new highs, bringing the stock roughly back to breakeven for the year Tipranks. Evoke Pharma’s stock has experienced extreme volatility in recent weeks. After trading…
Denny’s Stock Soars on Buyout Bombshell – $620 M Deal, Q3 Misses & What’s Next

Denny’s Stock Soars on Buyout Bombshell – $620 M Deal, Q3 Misses & What’s Next

Stock Price & Recent Performance Denny’s stock was under pressure for most of 2025 before the buyout news. The share price started the year in the mid-single digits and drifted lower amid uninspiring financial results and sector-wide challenges. In fact, DENN hit a 52-week low of $2.85 earlier in the year Marketbeat, reflecting investors’ pessimism about growth prospects. By late…
Kenvue (KVUE) Stock Soars 20% on $48.7 B Buyout News – Q3 Earnings Beat and What’s Next

Kenvue (KVUE) Stock Soars 20% on $48.7 B Buyout News – Q3 Earnings Beat and What’s Next

Stock Price and Intraday Performance (Nov 3, 2025) Kenvue’s stock soared on the buyout news, delivering a sharp one-day gain. As of midday Nov. 3, KVUE traded around $17–$18, up roughly 18–20% intraday Reuters. Prior to the announcement, the stock had closed at $14.37 on Oct. 31 Stockanalysis, near its 52-week low of ~$14.02 Reuters Reuters. The takeover premium (deal…
Merger Showdown: Union Slams Crédit Agricole–Banco BPM Deal Over Job Cuts and “Deserted” Towns

Merger Showdown: Union Slams Crédit Agricole–Banco BPM Deal Over Job Cuts and “Deserted” Towns

Union Sounds Alarm on Bank Merger Italian bank workers’ union First CISL has delivered a stark warning about the rumored merger between Banco BPM and Crédit Agricole Italia. On October 31, the union publicly rejected the potential deal, saying it would come at a high social cost. “An eventual Crédit Agricole–Banco BPM operation will bring a new wave of branch…
Brighthouse Financial (BHF) Stock Soars on Takeover Buzz – Price Jump, Earnings Outlook & Expert Analysis

Brighthouse Financial (BHF) Stock Soars on Takeover Buzz – Price Jump, Earnings Outlook & Expert Analysis

Short-Term and Long-Term Outlook Deal or No Deal: In the short term, Brighthouse’s fate may hinge on the takeover negotiations. If Aquarian finalizes a buyout near $70/share, the stock could quickly gravitate toward that price (roughly 25% above where it traded post-rumor) and shareholders would lock in a substantial one-time gain Investing. Market watchers note that private equity interest in…
1 25 26 27 28 29 34

Stock Market Today

  • Salesforce stock hits seven-week low; investors watch Davos AI push
    January 18, 2026, 5:00 PM EST. Salesforce (CRM) closed Friday at $227.11, down about 2.8% and at its lowest close since Nov. 26, extending a four-session slide and dropping roughly 12% for the week, according to StockAnalysis and MarketWatch. U.S. markets will be closed Monday for MLK Day; trading resumes Tuesday. With no earnings update or guidance change, moves may be sentiment-driven. The company is pushing its Agentforce AI and an on-site concierge app, EVA, at the World Economic Forum in Davos (Jan. 19-23). SEC filings show director Neelie Kroes sold 3,893 shares near $238.70. Analysts, including Aptus Capital's David Wagner, warn AI monetization timing is uncertain and note a rotation into semiconductors.
Go toTop